Incidence of Exercise-Associated Hyponatremia and Its Association with Nonosmotic Stimuli of Arginine Vasopressin in the GNW100s Ultra-endurance Marathon

Clinical Journal of Sport Medicine

Volumn 25, Issue 4, 2015, Pages 347-354

  Cairns, Ross S ^a   Hew Butler, Tamara ^b  

^a Newcastle Sports Medicine   (Australia)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

arginine vasopressin; hyponatremia; interleukin 6; ultramarathon running

Indexed keywords

ARGIPRESSIN; GLUCOSE; INTERLEUKIN 6; SODIUM; GLUCOSE BLOOD LEVEL; IL6 PROTEIN, HUMAN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENDURANCE; ENVIRONMENTAL TEMPERATURE; EXERCISE; EXERCISE ASSOCIATED HYPONATREMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPONATREMIA; INCIDENCE; MALE; MARATHON RUNNER; OUTCOME ASSESSMENT; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; BODY WEIGHT; DRINKING BEHAVIOR; HYPOGLYCEMIA; METABOLISM; MIDDLE AGED; RISK FACTOR; RUNNING; STATISTICAL MODEL; TEMPERATURE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARGININE VASOPRESSIN; BLOOD GLUCOSE; BODY WEIGHT; COHORT STUDIES; DRINKING BEHAVIOR; HUMANS; HYPOGLYCEMIA; HYPONATREMIA; INCIDENCE; INTERLEUKIN-6; LINEAR MODELS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RUNNING; SODIUM; TEMPERATURE;

EID: 84936890510     PISSN: 1050642X     EISSN: 15363724     Source Type: Journal    
DOI: 10.1097/JSM.0000000000000144     Document Type: Article

References (39)

1. Noakes TD, Goodwin N, Rayner BL, et al. Water intoxication: a possible complication during endurance exercise. Med Sci Sports Exerc. 1985;17:370-375.
2. Hew-Butler T, Ayus JC, Kipps C, et al. Statement of the second international exercise-associated hyponatraemia consensus development conference, New Zealand, 2007. Clin J Sport Med. 2008;18:111-121.
3. Hiller WDB, O'Toole ML, Massimino F, et al. Plasma electrolyte and glucose changes during the Hawaiian ironman triathlon. Med Sci Sports Exerc. 1985;17(suppl):219.
4. Speedy DB, Noakes TD, Rogers IR, et al. Hyponatremia in ultradistance triathletes. Med Sci Sports Exerc. 1999;31:809-815.
5. Hew TD, Chorley JN, Cianca JC, et al. The incidence, risk factors, and clinical manifestations of hyponatraemia in marathon runners. Clin J Sport Med. 2003;13:41-47.
6. Almond CSD, Shin AY, Fortescue EB, et al. Hyponatremia among runners in the Boston marathon. N Engl J Med. 2005;352:1550-1556.
7. Mettler S, Rusch C, Frey WO, et al. Hyponatremia among runners in the Zurich marathon. Clin J Sport Med. 2008;18:344-349.
8. Chorley J, Cianca J, Divine J. Risk factors for exercise-associated hyponatremia in non-elite marathon runners. Clin J Sport Med. 2007;17:471-477.
9. Kipps C, Sharma S, Tunstall Pedoe D. The incidence of exercise-associated hyponatraemia in the London marathon. Br J Sports Med. 2011;45:14-19.
10. Hoffman MD, Stuempfle KJ, Rogers IR, et al. Hyponatremia in the 2009 161-km Western States endurance run. Int J Sports Physiol Perform. 2012;7:6-10.
11. Hoffman MD, Fogard K, Winger J, et al. Characteristics of 161-km ultramarathon finishers developing exercise-associated hyponatremia. Res Sports Med. 2013;21:164-175.
12. Hoffman MD, Hew-Butler T, Stuempfle KJ. Exercise-associated hyponatraemia and hydration status in 161-km ultramarathoners. Med Sci Sports Exerc. 2013;45:784-791.
13. Rogers IR, Hew-Butler T. Exercise-associated hyponatremia: overzealous fluid consumption. Wilderness Environ Med. 2009;20:139-143.
14. Hew-Butler T, Jordaan E, Stuempfle KJ, et al. Osmotic and non-osmotic regulation of arginine vasopressin during prolonged endurance exercise. J Clin Endocrinol Metab. 2008;93:2072-2078.
15. Hew-Butler T. Arginine vasopressin, fluid balance and exercise. Is exercise-associated hyponatremia a disorder of arginine vasopressin secretion. Sports Med. 2010;40:459-479.
16. Hew-Butler T, Verbalis JG, Noakes TD. Updated fluid recommendation: from the international marathon medical directors association (IMMDA). Clin J Sport Med. 2006;16:283-292.
17. Noakes TD, Sharwood K, Speed D, et al. Three independent biological mechanisms cause exercise-associated hyponatraemia: evidence from 2,135 weighed competitive athletic performances. Proc Natl Acad Sci U S A. 2005;102:18550-18555.
18. Wharam PC, Speedy DB, Noakes TD, et al. NSAID use increases the risk of developing hyponatraemia during and ironman triathlon. Med Sci Sports Exerc. 2006;38:618-622.
19. Walker RJ, Fawcett JP, Flannery EM, et al. Indomethacin potentiates exercise-induced reduction in renal hemodynamics in athletes. Med Sci Sports Exerc. 1994;26:1302-1306.
20. Verbalis JG. Disorders of body water homeostasis. Best Pract Res Clin Endocrinol Metab. 2003;17:471-503.
21. Baylis PH, Heath DA. Plasma arginine vasopressin response to insulin-induced hypoglycaemia. Lancet. 1977;2:428-430.
22. Baylis PH, Zerbe RL, Robertson GL. Arginine-vasopressin response to insulin-induced hypoglycaemia in man. J Clin Endocr Metab. 1981;53:935-940.
23. Chiodera P, Coiro V. Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man. J Neural Transm Gen Sect. 1991;83:121-126.
24. Paro FM, Almeida MC, Carnio EC, et al. Role of L-glutamate in systemic AVP-induced hypothermia. J Appl Physiol. 2003;94:271-277.
25. Richmond CA. The role of arginine vasopressin in thermoregulation during fever. J Neurosci Nurs. 2003;35:281-286.
26. Bradford CD, Cotter JD, Thorburn MS, et al. Exercise can be pyrogenic in humans. Am J Physiol Requl Integr Comp Physiol. 2007;292:R143-R149.
27. Siegel AJ. Exercise-associated hyponatremia: role of cytokines. Am J Med. 2006;119:S74-S78.
28. Mastorakos G, Weber JS, Magiakou M-A, et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab. 1994;79:934-939.
29. Gionis D, Ilias I, Mantzos E, et al. Hypothalamic-pituitary-adrenal axis and interleukin-6 activity in children with head trauma and syndrome of inappropriate secretion of antidiuretic hormone. J Pediatr Endocrinol Metab. 2003;16:49-54.
30. Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol. 1998;508:949-953.
31. Steensberg A, van Hall G, Osada T, et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529:237-242.
32. Ostrowski K, Schjerling P, Pedersen BK. Physical activity and plasma interleukin-6 in humans - effect of intensity of exercise. Eur J Appl Physiol. 2000;83:512-515.
33. Margeli A, Skenderi K, Tsironi M, et al. Dramatic elevations of interleukin-6 and acute-phase reactants in athletes participating in the ultradistance foot race spartathlon: severe systemic inflammation and lipid and lipoprotein changes in protracted exercise. J Clin Endocrinol Metab. 2005;90:3914-3918.
34. Van Hall G, Steensberg A, Sacchetti M, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003;88:3005-3010.
35. Holmes AG, Watt MJ, Febbraio MA. Suppressing lipolysis increases interleukin-6 at rest and during prolonged moderate-intensity exercise in humans. J Appl Physiol. 2004;97:689-696.
36. Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ. Exerc Sport Sci Rev. 2005;33:114-119.
37. Fa¨ldt J, Wernstedt I, Fitzgerald SM, et al. Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology. 2004;145:2680-2686.
38. Chikanza IC, Petrou P, Chrousos G. Perturbations of arginine vasopressin secretion during inflammatory stress. Pathophysiological implications. Ann N Y Acad Sci. 2000;917:825-834.
39. Wilkerson JE, Gutin B, Horvath SM. Exercise-induced changes in blood, red cell, and plasma volumes in man. Med Sci Sports. 1977;9:155-158.